Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodbois Regulatory News (WBI)

  • This share is currently suspended. It was suspended at a price of 0.03
  • There is currently no data for WBI

Additional Share Option Awards / Director dealing

5 Jul 2017 07:00

RNS Number : 1307K
Obtala Limited
05 July 2017
 

05 July 2017

Obtala Limited

("Obtala", the "Group" or the "Company")

(AIM: OBT)

 

Additional Share Option Awards/Director dealing

 

 

Obtala Limited (AIM:OBT), the African focused agricultural and forestry company, is pleased to provide the following update.

 

Share Option Awards

 

The Company has approved the issue of share option awards to recently appointed management, including non-executive director Jessica Camus. Share option awards were made on the following structure within the company's existing share scheme:

 

Vesting Date Trigger Price Award Amounts

30 June 2018 20p 1.75m options

30 June 2019 25p 1.75m options

30 June 2020 30p 1.75m options

30 June 2021 35p 1.75m options

 

· The share options only become exercisable upon the Obtala monthly VWAP stock price being above the trigger price for 3 consecutive months at or after the vesting date.

· All tranches of the above options expire on 30th June 2026 regardless of whether they have been exercisable or not. 

· The exercise price for the options is 18p.

· If the awardee is not in the employment of a Group company at the time of vesting then the awards are forfeit.

 

The awards will be distributed to management of the following basis:

 

Carnel Geddes Group Accountant 250k per tranche (1m total)

Martin Collins Head of New Business 250k per tranche (1m total)

Adam Barker New Business 500k per tranche (2m total)

Jessica Camus Non-executive Director 250k per tranche (1m total)

Benjamin Salter Global Head of HSSE 250k per tranche (1m total)

Ulrica Marshall Public Relations Advisor 250k per tranche (1m total)

 

 

Miles Pelham, Chairman of Obtala comments:

"The further issue of performance based incentivisation to management underlines our commitment to appropriate and adequate incentivisation of employees which aligns interests with all stakeholders. As we work through this period of rapid production expansion it is essential motivation levels are high and operational/execution risk is overseen diligently.

 

Following this grant we now have 22m share options outstanding compared with 21m following last June's awards. The narrow difference is due to 6m share options being forfeit by leavers."

 

 

Obtala Limited

Miles Pelham - ChairmanPaul Dolan - CEO

www.obtala.com

+44 (0)20 7099 1940

ZAI Corporate Finance Limited (Nomad)

John Treacy / Ray Zimmerman

+44 (0)20 7060 2220

Brandon Hill Capital (Joint Broker)

Jonathan Evans

+44 (0)20 3463 5000

Beaufort Securities Limited (Joint Broker)

Jon Belliss

+44 (0)20 7382 8300

 

This announcement contains information which was previously inside information for the purposes of Article 7 of the Market Abuse Regulation EU Regulation 596/2014. 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSDFULFWSEDW
Date   Source Headline
27th Jun 20247:00 amRNSAppointment of Independent Non-Executive Director
24th Jun 20247:00 amRNS$5m Trade Finance Facility Completed
12th Jun 20247:00 amRNSBoard Changes & Trading Update
10th Jun 20247:00 amRNSUpdate on Publication of Financial Statements
23rd May 20241:43 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSMozambique Operations to be Divested
8th Feb 20247:05 amRNS£2.0m Exercise of Warrants to scale-up production
8th Feb 20247:00 amRNS$5m Trade Finance, Gabon Progress & 2024 Outlook
12th Jan 20247:00 amRNSIssuance of Shares and Warrants
5th Jan 20247:00 amRNSCEO Departure Commences Restructuring
29th Dec 202312:27 pmRNSResults of Annual General Meeting
29th Dec 20237:00 amRNSBoard Change, Strategic Initiatives & Joint Broker
4th Dec 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSNotice of Annual General Meeting
29th Sep 20237:00 amRNSHalf Year Results
30th Aug 20239:05 amRNSStatement re Share Price Movement
29th Jun 20231:30 pmRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSSubscription, Debt Refinancing & Issue of Warrants
16th Jun 202312:00 pmRNSResults of General Meeting
9th Jun 20237:00 amRNSAudited results for FY 2022
6th Jun 20237:00 amRNSDebt Repayment Terms and Corporate Update
30th May 20237:00 amRNSNotice of General Meeting and Posting of Circular
19th Apr 202311:45 amRNSTR-1
19th Apr 20237:14 amRNSFacility with Sydbank A/S ("Sydbank")
11th Apr 20237:01 amRNSQ1 2023 Update
11th Apr 20237:00 amRNSConditional Award of Afforestation Project
13th Mar 20237:00 amRNSPlacing of £3 million
10th Mar 20231:00 pmRNSTR-1
10th Mar 202312:41 pmRNSResponse to market speculation
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 202310:40 amRNSTR-1
24th Feb 202311:15 amRNSTR-1
31st Jan 20231:45 pmRNSTR-1
12th Jan 20237:00 amRNSQ4 2022 update
5th Dec 20225:30 pmRNSTR-1
11th Nov 20227:00 amRNSConversion of 55 million Non-Voting Shares
1st Nov 20228:15 amRNSTR-1
27th Oct 20225:15 pmRNSConversion of 60 million Non-Voting Shares
21st Oct 20227:00 amRNSTR-1
17th Oct 20227:00 amRNSQ3 2022 Upate an Boar change
17th Oct 20227:00 amRNSQ3 2022 Update and Board change
26th Sep 20224:15 pmRNSTR-1
26th Sep 20227:00 amRNSConversion of 60 million Non-Voting Shares
17th Aug 20227:00 amRNSEighth Ranking in SPOTT Transparency Assessment
10th Aug 20229:00 amRNSExercise of Options
4th Aug 20227:00 amRNSHalf Year Results
11th Jul 20227:00 amRNSQ2 2022 update
27th Jun 20227:00 amRNSConversion of 65 million Non-Voting Shares
16th Jun 20227:00 amRNSConversion of $243,591 of Convertible Bonds
14th Jun 20227:00 amRNSConversion of $50,000 of Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.